ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2021Brave Warrior AdvisorsSell-18,3131,145,416$437,320
Q2 2021Vulcan Value PartnersSell-119,1991,180,580$450,746
Q2 2021Sequoia FundBuy672,1561,844,001$704,040
Q2 2021First Eagle U.S. ValueSell-25,6731,954,383$746,183
Q1 2021Eagle Capital ManagementSell-232,0022,220,997$797,227
Q1 2021Yacktman Asset ManagementBuy7,893406,639$145,963
Q1 2021Sound Shore ManagementBuy740222,186$79,754
Q1 2021Sequoia Financial AdvisorsBuy2361,678$602
Q1 2021Brave Warrior AdvisorsBuy392,5941,163,729$417,720
Q1 2021Sequoia FundBuy1,171,8451,171,845$420,634
Q1 2021Vulcan Value PartnersSell-517,5281,299,779$466,556
Q1 2021First Eagle U.S. ValueSell-52,2991,980,056$710,741
Q4 2020Eagle Capital ManagementSell-130,9662,452,999$787,633
Q4 2020Yacktman Asset ManagementSell-1,048398,746$128,033
Q4 2020Sound Shore ManagementSell-766,395221,446$71,104
Q4 2020Sequoia Financial AdvisorsSell-11,442$463
Q4 2020Renaissance Technologies LLCBuy91,500237,273$76,186
Q4 2020Brave Warrior AdvisorsBuy7,208771,135$247,603
Q4 2020Vulcan Value PartnersSell-15,1781,817,307$583,519
Q4 2020First Eagle U.S. ValueSell-135,6982,032,355$652,569
Q3 2020Dodge & Cox Stock FundSell-1601,100$295
Q3 2020Eagle Capital ManagementBuy425,1882,583,965$694,027
Q3 2020Yacktman Asset ManagementBuy15,257399,794$107,381
Q3 2020Sequoia Financial AdvisorsBuy21,443$388
Q3 2020Renaissance Technologies LLCSell-368,300145,773$39,153
Q3 2020Viking Global InvestorsSell-1,288,227522,405$140,313
Q3 2020Brave Warrior AdvisorsSell-7,541763,927$205,183
Q3 2020Vulcan Value PartnersBuy5,9951,832,485$492,187
Q3 2020First Eagle U.S. ValueBuy8,5702,168,053$582,317
Q2 2020Dodge & Cox Stock FundBuy601,260$331

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.